PAVmed Income Statement (2021-2025) | PAVM

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) -0.00M0.20M0.30M0.19M0.08M0.11M0.45M0.17M0.79M1.05M1.01M0.98M0.01M0.01M0.01M0.01M0.08M
Cost of Revenue (Quarter) 1.39M1.88M0.14M8.75M0.37M4.90M4.74M5.76M1.35M4.34M1.78M12.77M4.31M1.67M0.04M0.15M0.25M0.04M0.06M0.78M
Gross Profit (Quarter) 0.06M-0.14M-0.18M-4.66M-5.65M-0.90M-4.17M-0.99M-11.72M-3.30M-0.69M-0.14M-0.24M-0.04M-0.05M-0.70M
Operating items
Amortization - Intangibles (Quarter) 0.02M0.12M0.12M0.65M0.51M0.51M0.51M0.51M0.51M0.51M0.37M0.10M
Research & Development (Quarter) 3.31M4.26M5.30M6.97M5.93M6.74M6.20M6.67M4.05M3.47M3.16M3.60M1.94M1.64M0.81M0.79M0.79M1.09M1.83M
Selling, General & Administrative (Quarter) 3.38M6.84M6.11M9.11M9.47M11.20M10.37M10.16M10.41M6.65M6.86M7.03M6.68M7.01M4.19M4.38M3.67M3.50M4.69M
Other Operating Expenses (Quarter) -9.51M1.88M2.45M3.90M-17.13M5.55M6.87M7.88M1.00M6.43M6.01M0.20M0.28M0.26M0.26M0.33M
Operating Expenses (Quarter) 8.08M12.97M13.87M19.98M19.82M23.48M23.44M24.71M20.85M16.65M16.32M17.43M15.05M14.66M5.20M5.45M4.72M4.85M6.86M
Operating Income (Quarter) -8.08M-12.97M-13.67M-19.68M-19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M-6.80M
EBIT (Quarter) -8.08M-12.97M-13.67M-19.68M-19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M-6.80M
Non-operating items
Other Non Operating Income (Quarter) -2.03M0.30M5.45M0.00M-5.62M-6.57M0.03M-1.81M-0.26M-6.22M-1.02M0.20M0.21M0.33M-1.53M0.06M-0.06M
Non Operating Income (Quarter) -2.03M0.30M0.00M-5.62M-6.57M0.03M-1.81M-1.41M-6.22M-1.02M-4.48M-1.23M6.33M24.07M-7.61M-1.17M4.05M
Net income details
EBT (Quarter) -10.11M-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M
Profit After Tax (Quarter) -10.11M-11.47M-13.67M-17.22M-16.87M-25.52M-26.13M-34.72M-17.93M-14.54M-21.75M-17.41M-15.21M-10.83M-14.87M18.62M-12.32M-6.01M-1.26M
Equity Income (Quarter) 0.12M21.00M-10.64M-4.38M2.50M
Income from Non-Controlling Interests (Quarter) -0.68M-1.20M-1.44M-2.46M-2.76M-3.58M-3.81M-4.11M-4.28M-3.35M-4.08M-3.37M-3.30M-4.09M-0.29M-0.34M-0.40M-0.63M-1.49M
Income from Continuing Operations (Quarter) -10.11M-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M
Consolidated Net Income (Quarter) -10.11M-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M
Income towards Parent Company (Quarter) -10.11M-12.67M-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M-2.76M
Preferred Dividend Payments (Quarter) 0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M-0.24M0.09M0.09M0.09M0.09M
Net Income towards Common Stockholders (Quarter) -9.51M-11.54M-12.29M-17.29M-16.94M-25.59M-26.20M-20.53M-18.00M-14.61M-17.75M-15.90M-22.79M-10.91M1.35M17.70M-13.31M-6.33M-1.83M
Additional items
EPS (Basic) (Quarter) -0.13-0.14-0.15-0.24-0.20-0.29-0.29-14.25-2.78-2.10-2.38-1.93-2.62-1.1995.851.28-0.74-0.29-5.52
EPS (Weighted Average and Diluted) (Quarter) -0.29-0.29-14.25-2.78-2.10-2.38-1.93-2.62-1.1914.110.34-0.74-0.29-5.52
Shares Outstanding (Weighted Average) (Quarter) 73.95M78.12M79.87M77.52M86.34M86.69M89.76M5.94M6.47M6.72M6.97M7.23M8.69M9.15M0.32M13.88M15.99M21.55M0.67M
Shares Outstanding (Diluted Average) (Quarter) 86.96M89.76M5.94M6.47M6.72M6.97M7.23M8.69M8.92M2.17M52.50M18.08M21.55M0.67M
EBITDA (Quarter) -8.08M-12.97M-13.67M-19.68M-19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M-6.80M
Interest Expenses (Quarter) 0.00M0.52M0.53M0.23M0.18M0.23M0.16M0.02M0.02M0.01M0.01M0.00M0.00M0.01M0.01M